Table 2. 5-Year survivals in clinical stage I OGCT patients by stage and histology.
| Variable | N | LND-1 (%) | LND+1 (%) | LND+3C (%) | P-value |
|---|---|---|---|---|---|
| Overall | 1083 | 96.9 | 97.7 | 93.4 | 0.5 |
| Clinical stage | |||||
| Stage IA | 779 | 97.3 | 98.9 | 91.7 | 0.18 |
| Stage IB | 30 | 90 | 100 | 100 | 0.50 |
| Stage IC | 214 | 97.4 | 94 | 94.4 | 0.86 |
| Stage I NOS | 60 | 94.2 | 94.1 | 100 | 0.59 |
| Histology | |||||
| Dysgerminoma | 354 | 97.9 | 97.5 | 97.5 | 0.99 |
| MT | 516 | 98.3 | 98.6 | 83.3 | 0.10 |
| MGCT/PNDCT | 213 | 92.4 | 96.3 | 75 | 0.38 |
| MT+MGCT/PNDCT | 729 | 96.6 | 97.8 | 79.5 | 0.053 |
Abbreviations: MGCT/PNDCT=mixed germ cell tumour with pure nondysgerminoma cell tumour; MT=malignant teratoma; OGCT=ovarian germ cell tumour.